These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 8678954)

  • 1. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
    Sugino K; Ito K; Ozaki O; Mimura T; Iwasaki H; Wada N
    World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.
    Sugino K; Mimura T; Toshima K; Iwabuchi H; Kitamura Y; Kawano M; Ozaki O; Ito K
    J Endocrinol Invest; 1993 Mar; 16(3):195-9. PubMed ID: 8099920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early recurrence of hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Kure Y; Iwasaki H; Wada N; Matsumoto A; Ito K
    World J Surg; 1995; 19(4):648-52. PubMed ID: 7676715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.
    Okamoto T; Fujimoto Y; Obara T; Ito Y; Aiba M
    World J Surg; 1992; 16(4):690-5; discussion 695-6. PubMed ID: 1413838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term follow up after antithyroid drug treatment in Graves' disease].
    Wille T; Müller B; Noth D; Bürgi U; Diem P
    Praxis (Bern 1994); 2006 Jul; 95(29-30):1121-7. PubMed ID: 16916174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum TSH receptor antibody (TRAb) values in patients with Graves' disease after total or subtotal thyroidectomy.
    Takamura Y; Nakano K; Uruno T; Ito Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
    Endocr J; 2003 Oct; 50(5):595-601. PubMed ID: 14614216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term outcomes of thyroid function after subtotal thyroidectomy for Graves' hyperthyroidism.
    Lin YS; Lin JD; Hsu CC; Yu MC
    J Surg Res; 2017 Dec; 220():112-118. PubMed ID: 29180171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of Graves' disease: subtotal or total thyroidectomy?
    Miccoli P; Vitti P; Rago T; Iacconi P; Bartalena L; Bogazzi F; Fiore E; Valeriano R; Chiovato L; Rocchi R; Pinchera A
    Surgery; 1996 Dec; 120(6):1020-4; discussion 1024-5. PubMed ID: 8957489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early hypothyroidism after subtotal thyroidectomy in patients with Graves' disease--the role of the preoperative conservative treatment and hormonal status.
    Nonchev BI; Terzieva DD; Dimov RS; Mateva NG; Tsvetkova TZ; Dimitrakov DY
    Folia Med (Plovdiv); 2005; 47(3-4):40-5. PubMed ID: 16761393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
    Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
    Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of thyroidectomy for Graves' disease: A meta-analysis.
    Palit TK; Miller CC; Miltenburg DM
    J Surg Res; 2000 May; 90(2):161-5. PubMed ID: 10792958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid surgery for Graves' disease and Graves' ophthalmopathy.
    Liu ZW; Masterson L; Fish B; Jani P; Chatterjee K
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010576. PubMed ID: 26606533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study.
    Cappelli C; Gandossi E; Castellano M; Pizzocaro C; Agosti B; Delbarba A; Pirola I; De Martino E; Rosei EA
    Endocr J; 2007 Dec; 54(5):713-20. PubMed ID: 17675761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
    Mori Y; Matoba N; Miura S; Sakai N; Taira Y
    World J Surg; 1992; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication.
    Smith J; Brown RS
    Thyroid; 2007 Nov; 17(11):1103-7. PubMed ID: 17822376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.